EDGAR Filing Documents for 0001193125-21-248190

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-21-248190

Filing Date

2021-08-17

Accepted

2021-08-16 21:54:35

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3/A	d185512ds3a.htm	S-3/A	277618
2	GRAPHIC	g185512g15w44.jpg	GRAPHIC	41750
	Complete submission text file	0001193125-21-248190.txt		331929

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-258510 | Film No.: 211180776
SIC: 2834 Pharmaceutical Preparations